TP53 and cancer: The well-known tumor suppressor gene TP53 is frequently mutated in human cancers (Giacomelli et al. 2018); this mutation is one of the most common genetic changes in HCC and is associated with the progression and prognosis of HCC (Li et al. 2022; Yang, et al. 2021).